A detailed history of Heron Financial Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Heron Financial Group, LLC holds 10,117 shares of JNJ stock, worth $1.55 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
10,117
Previous 9,980 1.37%
Holding current value
$1.55 Million
Previous $1.55 Million 8.28%
% of portfolio
0.9%
Previous 0.85%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $21,145 - $22,757
137 Added 1.37%
10,117 $1.67 Million
Q1 2023

Apr 19, 2023

BUY
$151.05 - $180.26 $142,893 - $170,525
946 Added 10.47%
9,980 $1.55 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $4,966 - $5,573
31 Added 0.34%
9,034 $1.6 Million
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $36,299 - $40,392
-225 Reduced 2.44%
9,003 $1.47 Million
Q2 2022

Jul 29, 2022

SELL
$168.19 - $186.01 $15,473 - $17,112
-92 Reduced 0.99%
9,228 $1.64 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $54,874 - $62,317
347 Added 3.87%
9,320 $1.65 Million
Q4 2021

Feb 04, 2022

BUY
$155.93 - $173.01 $26,508 - $29,411
170 Added 1.93%
8,973 $1.53 Million
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $2,422 - $2,692
15 Added 0.17%
8,803 $1.42 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $48,641 - $52,176
305 Added 3.6%
8,788 $1.45 Million
Q1 2021

Apr 14, 2021

BUY
$153.07 - $170.48 $52,809 - $58,815
345 Added 4.24%
8,483 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $24,542 - $28,171
-179 Reduced 2.15%
8,138 $1.31 Million
Q3 2020

Oct 15, 2020

BUY
$140.38 - $153.83 $219,694 - $240,743
1,565 Added 23.18%
8,317 $1.23 Million
Q2 2020

Jul 20, 2020

BUY
$128.81 - $155.51 $24,473 - $29,546
190 Added 2.9%
6,752 $961,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $836,655 - $960,939
6,562 New
6,562 $997,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Heron Financial Group, LLC Portfolio

Follow Heron Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heron Financial Group, LLC with notifications on news.